Methods This retrospective, database study used Optums de-identified Clinformatics Data Mart Database to identify glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment-nave adult patients with type 2 diabetes (T2D) initiating semaglutide QW, dulaglutide, liraglutide, or exenatide QW between January 1, 2018 and April 30, 2019
Si es necesario, paso a 0,5 mg, y solo llego a 1 mg en pacientes con obesidad severa o gran dificultad para bajar
At RescueMD, our online weight loss program includes visits with a physician or nurse practitioner, dietitian support, and lab work to help create a personalized treatment plan based on your health needs
Pricing, guarantee terms, medical group affiliations, pharmacy partners, and service availability may change after publication
This metabolic overlap has led some patients and clinicians to wonder whether medications targeting metabolic pathways, such as GLP-1 receptor agonists, might offer benefits for individuals with Hashimoto's disease
To check your eligibility, you can take your health quiz